A phase 2 dose exploratory study of K-877

Trial Profile

A phase 2 dose exploratory study of K-877

Phase of Trial: Phase II

Latest Information Update: 01 Jun 2016

At a glance

  • Drugs Pemafibrate (Primary) ; Fenofibrate
  • Indications Dyslipidaemias; Hypertriglyceridaemia; Low HDL cholesterol
  • Focus Therapeutic Use
  • Sponsors Kowa
  • Most Recent Events

    • 20 Nov 2013 Results presented at the 86th Annual Scientific Sessions of the American Heart Association.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top